GLP-1 Check — India's GLP-1 Information & Self-Assessment Tool

Ozempic Alternatives in India (2026)

Updated May 2026 · Indian guideline + DCGI-approved options

The short answer

The cheapest Ozempic alternative in India is Sundae (Eris × Natco) at ₹220 per shot — same active molecule as Ozempic at roughly 25× lower cost. Other options: Noveltreat / Sematrinity (Sun Pharma, ₹750–2,000/month), Obeda (Dr Reddy’s, ₹4,200/month), Semabest (MSN Labs, ₹3,990/month), or Mounjaro (tirzepatide, different molecule, ₹14,000–27,500/month, more effective). Take the 5-min eligibility check.

Not sure which alternative fits your case?

The 5-minute Indian-guideline eligibility check maps your fit.

Take the free assessment →

Why look for an Ozempic alternative?

In India, the #1 reason patients search for Ozempic alternatives is cost. Ozempic costs ₹5,660–9,100/month after Novo Nordisk’s April 2026 price cut (a 36% reduction in response to generic competition). For patients needing 12+ months of therapy, total cost easily crosses ₹70,000–110,000/year on Ozempic alone — before consults, labs, and ancillary costs.

Post-patent expiry (March 20, 2026), 10+ Indian generic semaglutide brands launched at dramatically lower prices. The active molecule is identical to Ozempic; DCGI-approved generics demonstrate bioequivalence. Other reasons patients seek alternatives: pen-design preference, brand stock issues in tier-2/3 cities, off-label use considerations, and (for some) a switch to tirzepatide (Mounjaro) for stronger weight outcomes.

Option 1: Indian generic semaglutides (cheapest)

Same active molecule as Ozempic at 3–25× lower cost. All DCGI-approved; all bioequivalent. Best path for cost-sensitive patients on long-term therapy.

BrandManufacturerMonthly costIndication
SundaeEris × Natco₹220 / shotT2D + Obesity
Noveltreat / SematrinitySun Pharma₹750–2,000Obesity / T2D
SemasizeAlkem₹1,800–3,500T2D + Obesity
SemaglynZydus Lifesciences₹2,200–5,500T2D + Obesity
SemanextLupin (via Zydus)₹2,200T2D + Obesity
SemabestMSN Laboratories₹3,990T2D
ObedaDr Reddy’s + USV₹4,200T2D

See the full India brand directory →

Option 2: Wegovy (same molecule, obesity dose)

Wegovy is Novo Nordisk’s obesity-indicated semaglutide — same active molecule as Ozempic, but at higher doses (up to 2.4 mg weekly vs Ozempic’s 2 mg max). DCGI-approved for chronic weight management; carries the SELECT cardiovascular outcomes label. Price ₹5,660–16,400/month, plus the Emcure-distributed Poviztra variant at ₹3,999–8,999/month for the same molecule.

Detailed comparison: Ozempic vs Wegovy in India →

Option 3: Rybelsus (oral tablet semaglutide)

Rybelsus is the oral tablet form of semaglutide — same active molecule as Ozempic but a daily tablet (3 mg, 7 mg, 14 mg) instead of weekly injection. DCGI-approved for type 2 diabetes. Practical trade-offs: daily dosing requires strict food-timing discipline (30 minutes fasting before/after), and absorption variability means slightly lower efficacy than the injectable form. Indian generic oral semaglutide: Torrent’s Semalix tablets (3/7/14 mg, T2D).

Option 4: Mounjaro (tirzepatide — different molecule, stronger weight loss)

Mounjaro(Eli Lilly’s tirzepatide) is a different molecule from Ozempic — a dual GIP + GLP-1 agonist vs Ozempic’s GLP-1-only mechanism. Clinical evidence: SURPASS-2 head-to-head (40 weeks, NEJM 2021) showed tirzepatide superior to semaglutide 1 mg at every dose tested. SURMOUNT-1 achieved 22.5% body weight reduction at 15 mg over 72 weeks vs Wegovy’s ~15% at 2.4 mg.

Trade-off: cost. Mounjaro runs ₹14,000–27,500/month — substantially above any semaglutide option. Best fit when maximum efficacy matters more than cost. No Indian generic tirzepatide expected before ~2028-2030 (Eli Lilly patent status).

Detailed comparison: Semaglutide vs Tirzepatide in India →

Frequently asked questions

What is the cheapest Ozempic alternative in India?+
Sundae (Eris Lifesciences × Natco Pharma) at ₹220 per shot is the globally lowest-priced semaglutide product — roughly 25× cheaper than Ozempic's ₹5,660+/month. It uses a multi-dose vial format (best for clinic / hospital administration); a pen device launched April 2026 for self-administration. Other affordable options: Noveltreat (Sun Pharma, ₹750-2,000/month), Obeda (Dr Reddy's + USV, ₹4,200/month), Semabest (MSN Laboratories, ₹3,990/month).
Are Indian generic semaglutides as effective as Ozempic?+
Yes — the active molecule (semaglutide) is identical. DCGI-approved Indian generics must demonstrate bioequivalence to the innovator (Novo Nordisk's Ozempic). Clinical efficacy follows the molecule, not the brand. Differences between generics and Ozempic are in pen design, manufacturer support programmes, and price — not in the biological effect on HbA1c, weight, or cardiovascular outcomes.
Is Mounjaro a better alternative to Ozempic?+
Mounjaro (tirzepatide, Eli Lilly) is a different molecule — a dual GIP + GLP-1 agonist vs Ozempic's GLP-1-only mechanism. SURPASS-2 head-to-head over 40 weeks: tirzepatide outperformed semaglutide 1 mg at every dose tested. At tirzepatide 15 mg: HbA1c -2.30% vs semaglutide 1 mg -1.86%, and weight -11.2 kg vs -5.7 kg. Even at tirzepatide 5 mg (lowest dose), HbA1c -2.01% / weight -7.6 kg beat semaglutide 1 mg. Trade-off: Mounjaro costs ₹14,000-27,500/month vs Ozempic's ₹5,660+. If maximum efficacy matters and budget allows, Mounjaro is better; if cost matters, semaglutide generics are.
What about Wegovy as an Ozempic alternative?+
Wegovy is Novo Nordisk's obesity-indication semaglutide (the same molecule as Ozempic but at a higher 2.4 mg dose). If your goal is weight management without diabetes, Wegovy is the on-label alternative (₹5,660-16,400/month). Ozempic is approved for type 2 diabetes; Wegovy for chronic weight management. The molecule is identical, but the regulatory label and maximum approved dose differ.
Can I take Rybelsus (oral) instead of Ozempic (injection)?+
Rybelsus is the oral tablet form of semaglutide (3 mg, 7 mg, 14 mg daily), same active molecule as Ozempic. It is DCGI-approved for type 2 diabetes only. Efficacy is similar but the daily oral route has more food-timing requirements (30 minutes fasting before/after) and may produce slightly less weight loss than the weekly injection. Useful for patients with injection aversion. Indian generic oral semaglutide is available via Torrent's Semalix (3/7/14 mg).
Why is Ozempic so expensive in India compared to Indian generics?+
Novo Nordisk holds the innovator-brand position with the full clinical trial data package (SUSTAIN-6 cardiovascular outcomes, SELECT trial). Post-patent expiry (March 20, 2026), Indian generic manufacturers can produce the same molecule without recouping R&D costs, so prices drop dramatically. Novo Nordisk cut Ozempic prices ~36% in April 2026 in response to generic competition, but Indian generics remain 3-25× cheaper.
Is it safe to switch from Ozempic to an Indian generic semaglutide?+
Yes — under your physician's supervision. The molecule is identical, so clinical outcomes shouldn't differ. Practical considerations: confirm your dose strength is available in the generic brand (most cover the full 0.25-1 mg range), ensure pen design works for you, and check stock at your local pharmacy. Many Indian endocrinologists routinely switch patients from Ozempic to generics for cost reasons.

Related guides

GLP-1 therapy cost in India 2026 →All India brand comparisons →All India semaglutide brands →Generic tirzepatide / Mounjaro in India →

Find your right alternative

5-minute Indian-guideline eligibility check. Maps your profile to the right molecule, dose, and budget.

Take the free assessment →

Prices reflect publicly known MRP and observed pharmacy pricing as of May 2026. All GLP-1 therapies (semaglutide, tirzepatide) are Schedule H drugs in India requiring a doctor’s prescription. Always consult a qualified physician before starting or switching therapy. GLP-1 Check is informational and not a substitute for clinical judgment.